bioMérieux announces that VIDAS 3, the latest generation of VIDAS, received FDA 510(k) clearance. This instrument furthers the offerings of the VIDAS immunoassay product range, VIDAS and mini VIDAS. It features enhanced automation, in particular the pre-analytical section from the bar-coded primary tube including dilution, improved traceability, and new software capabilities, as well as a quality control program in compliance with laboratory certification standards. This low throughput immunoassays platform can perform tests on demand, individually, or in series, 24 hours a day and 7 days a week. As a result, it is suited to centralized, as well as satellite laboratories, bringing both versatility and reliability to health care professionals who are able to optimize their workflows and guarantee the quality of biological testing. VIDAS 3 uses the same reagents as the other instruments in the VIDAS range. The single test concept and new features make the VIDAS 3 particularly well adapted to meet the needs of labs supporting emergency departments and critical care.